February 8, 2008 – CryoLife Inc. said it received FDA 510(k) clearance for its CryoValve SG pulmonary human heart valve processed with the company's SynerGraft technology, which is designed to remove allogeneic donor cells and cellular remnants from the valve without compromising the integrity of the underlying collagen matrix.

CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.

Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:

February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.

February 7, 2008 - A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells is transplanted into their leg muscles with severely blocked arteries to try to grow new small blood vessels and restore circulation in their legs.

February 7, 2008 - Tryton Medical Inc.’s Side Branch Stent obtains CE Mark approval based on results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients, according to the manufacturer.

February 7, 2008 - Abiomed Inc. reported its third quarter fiscal 2008 revenue reached $16.0 million, up 24 percent compared to revenue of $12.9 million for the same period of fiscal 2007, marking a revenue high for Abiomed.

Total revenue for the third quarter of fiscal 2008 was, and Revenue in both the U.S. and Europe were also record highs for a quarter. Revenue for the nine months ended December 31, 2007 was $41.4 million, up 13 percent compared to revenue of $36.8 million in the first nine months of fiscal 2007.

February 6, 2008 - The Medical University of South Carolina (MUSC) opens the doors of Ashley River Tower, its new state-of-the-art hospital designed to treat patients with cardiovascular and digestive disease problems, marking the first step in the hospital’s multiphase expansion plan, which will ultimately replace the facility that for 50 years has served as the teaching hospital for MUSC.

McKesson’s ECG Management module, a component of Horizon Cardiology, is a fully integrated, Web-enabled, electrocardiography (ECG) waveform data management product, said the company.

The module reportedly enables clinicians to view or complete ECG exams along with all other cardiovascular procedures from one system. Furthermore, the module’s Web-enabled functionality allows physicians to read and confirm ECG exams from remote locations, said the company.

The PicomECG is a reportedly flexible and robust Web-based ECG management and distribution system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now